Update ESC guideline 2026: Heart failure

Acute heart failure 
Chronic heart failure  
Advanced heart failure 
Q and A

Heart failure in special populations

Withdraw therapy in HF with improved LVEF: 
new evidence! 
Revisited Traditional Therapy in Hypertrophic 
Cardiomyopathy (SGLT2i/RV pacing, BB/CCB)
Smart Testing for Cardiac Amyloidosis: Value Over Cost  
Q and A

Back to Basics: Using Old Tools Wisely in Modern Cardiology

Revisit digoxin: When and how to use digoxin wisely
ICD in non-ischemic CM: How to choose?
Electrolyte Therapy — Simple Cure or False Hope 
for Arrhythmias?    
Q and A

AHA/ACC guideline 2026: Acute pulmonary embolism

Top 10 messages from the guideline  
What are the obstacles to implementing in practice?  
Applying guidelines to real case
Q and A

Syncope: Memorable cases from the expert

Q and A

AF management in special populations: Case-based learning

Post-op AF
AF during sepsis/critical illness/hyperthyroid
AF in dialysis
OAC after AF ablation
AF with CCS 

Stroke prevention in special populations

Optimum duration of double therapy in AF-PCI, 
new evidence!
LAA occlusion vs DOAC, who wins?   
Resurrection of Factor XI inhibitor! 
Q and A

Cardiogenic shock: Learn from the real case!

AHA/ACC guideline 2025: Adult congenital heart disease

Top 10 messages from the guideline
Applying guidelines to real case 

Challenge in prosthetic valve management

Bioprosthetic valve dysfunction – redo-surgery
vs transcatheter
Fibrinolysis in prosthetic valve thrombosis
Prosthetic valve IE   
Q and A